some "dopes" to make me think ARWR is in some sort of competition with TKMR that ends this week. This is the second inning folks . . . look at ARWR's biggest institutional holders . . . a "Who's Who" in biopharma investing . . Baker Bros., Orbimed, Renaissance Capital, Millenium, SAC Capital . . . all my favorites to watch. Yes, smart money is diversified (including TKMR), but more all-star professional performers betting on ARWR . . . me too! News coming to take ARWR much higher in the coming months.